HLB Co., Ltd. (KOSDAQ:028300)
South Korea flag South Korea · Delayed Price · Currency is KRW
52,400
+300 (0.58%)
At close: Feb 11, 2026

HLB Co., Ltd. Revenue

HLB Co., Ltd. had revenue of 22.11B KRW in the quarter ending September 30, 2025, with 30.43% growth. This brings the company's revenue in the last twelve months to 80.73B, up 55.49% year-over-year. In the year 2024, HLB Co., Ltd. had annual revenue of 68.13B with 58.80% growth.

Revenue (ttm)
80.73B
Revenue Growth
+55.49%
P/S Ratio
86.23
Revenue / Employee
527.66M
Employees
153
Market Cap
6.96T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202468.13B25.23B58.80%
Dec 31, 202342.90B-136.81B-76.13%
Dec 31, 2022179.71B109.88B157.37%
Dec 31, 202169.83B13.65B24.30%
Dec 31, 202056.18B17.76B46.22%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SK Biopharmaceuticals675.41B
SK bioscience624.03B
PharmaResearch496.03B
Hugel404.19B
ALTEOGEN202.18B
LigaChem Biosciences159.27B
OliX Pharmaceuticals10.18B
D&D Pharmatech8.36B
Revenue Rankings